Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-04-14 20:20 | 2020-04-09 | EHI | WESTERN ASSET GLOBAL HIGH INCOME FUND INC. | Saba Capital Management, L.P. | 10% owner | Other | BUY | $8.38 | 121,547 | $1,018,041 | 8,496,634 | +1.5% |
| 2020-04-14 00:15 | 2020-04-09 | KWR | QUAKER CHEMICAL CORP | Gulf Hungary Holding Korlatolt Felelossegu Tarsasag | 10% owner | Miscellaneous Products of Petroleum & Coal | BUY | $134.58 | 3,404,453 | $458,171,285 | 3,404,453 | +100.0% |
| 2020-04-14 00:18 | 2020-04-13 | KROS | Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 437,499 | $6,999,984 | 149,262 | +100.0% |
| 2020-04-14 00:15 | 2020-04-13 | KROS | Keros Therapeutics, Inc. | Lazarus Alon | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 120,000 | $1,920,000 | 2,013,102 | +6.3% |
| 2020-04-14 00:16 | 2020-04-13 | KROS | Keros Therapeutics, Inc. | Nussbaum Ran | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 437,499 | $6,999,984 | 149,262 | +100.0% |
| 2020-04-14 00:13 | 2020-04-13 | KROS | Keros Therapeutics, Inc. | Kariv Tomer | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 437,499 | $6,999,984 | 149,262 | +100.0% |
| 2020-04-14 00:29 | 2020-04-13 | KROS | Keros Therapeutics, Inc. | Arkin Bio Ventures Limited Partnership | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 120,000 | $1,920,000 | 2,013,102 | +6.3% |
| 2020-04-14 00:12 | 2020-04-13 | KROS | Keros Therapeutics, Inc. | GORDON CARL L | Director | Pharmaceutical Preparations | BUY | $16.00 | 375,200 | $6,003,200 | 1,119,812 | +50.4% |
| 2020-04-14 02:02 | 2020-04-09 | SFIX | Stitch Fix, Inc. | SPURLOCK STEVEN M | 10% owner | Retail-Catalog & Mail-Order Houses | BUY | $15.80 | 1,000,000 | $15,804,700 | 1,000,000 | +100.0% |
| 2020-04-14 02:03 | 2020-04-09 | SFIX | Stitch Fix, Inc. | GURLEY J WILLIAM | Director, 10% owner | Retail-Catalog & Mail-Order Houses | BUY | $15.80 | 1,000,000 | $15,804,700 | 1,000,000 | +100.0% |
| 2020-04-14 00:17 | 2020-04-13 | KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Pharmaceutical Preparations | BUY | $16.00 | 375,200 | $6,003,200 | 1,119,812 | +50.4% |
| 2020-04-09 20:19 | 2020-04-07 | SPWR | N/A | TOTAL S.A. | Director, 10% owner | Other | BUY | $5.82 | 505,794 | $2,943,772 | 87,365,032 | +0.6% |
| 2020-04-09 18:20 | 2020-04-07 | MYOV | Myovant Sciences Ltd. | Sumitomo Chemical Co., Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $8.37 | 140,000 | $1,171,296 | 47,208,604 | +0.3% |
| 2020-04-09 23:11 | 2020-04-07 | MRSN | Mersana Therapeutics, Inc. | Hack Andrew A. F. | Director | Pharmaceutical Preparations | BUY | $5.99 | 3,445,667 | $20,649,538 | 3,445,667 | +100.0% |
| 2020-04-10 00:56 | 2020-04-08 | NGM | N/A | Svennilson Peter | Director, 10% owner | Other | BUY | $14.95 | 112,602 | $1,683,400 | 17,706,978 | +0.6% |
| 2020-04-10 00:52 | 2020-04-08 | NGM | N/A | COLUMN GROUP L P | 10% owner | Other | BUY | $14.95 | 112,602 | $1,683,400 | 1,540,071 | +7.9% |
| 2020-04-09 23:41 | 2020-04-01 | FRG | N/A | B. Riley Financial, Inc. | 10% owner | Other | BUY | $17.00 | 516,734 | $8,784,478 | 4,622,462 | +12.6% |
| 2020-04-09 23:58 | 2020-04-07 | TPB | Turning Point Brands, Inc. | Standard General L.P. | 10% owner | Tobacco Products | BUY | $20.69 | 136,545 | $2,824,433 | 9,978,918 | +1.4% |
| 2020-04-10 01:00 | 2020-04-07 | TPB | Turning Point Brands, Inc. | STANDARD DIVERSIFIED INC. | 10% owner | Tobacco Products | BUY | $20.69 | 136,545 | $2,824,433 | 9,978,918 | +1.4% |
| 2020-04-09 22:31 | 2020-04-07 | MRSN | Mersana Therapeutics, Inc. | MOTT DAVID M | Director | Pharmaceutical Preparations | BUY | $5.59 | 538,599 | $3,010,768 | 538,599 | +100.0% |
| 2020-04-10 01:44 | 2020-04-07 | IDRA | N/A | Pillar Invest Corp | 10% owner | Other | BUY | $1.52 | 3,039,514 | $4,620,061 | 6,260,832 | +94.4% |
| 2020-04-10 00:54 | 2020-04-08 | NGM | N/A | GOEDDEL DAVID V | Director, 10% owner | Other | BUY | $14.95 | 112,602 | $1,683,400 | 17,896,978 | +0.6% |
| 2020-04-08 14:51 | 2020-03-30 | TMRR | N/A | CHAN KONG HOI | Director, Officer, 10% owner - President | Other | BUY | $14.10 | 410,560 | $5,788,896 | 629,350 | +187.7% |
| 2020-04-09 03:33 | 2020-04-07 | ZNTL | Zentalis Pharmaceuticals, Inc. | VIKING GLOBAL INVESTORS LP | 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 725,000 | $13,050,000 | 4,443,284 | +19.5% |
| 2020-04-07 23:03 | 2020-04-03 | SAIC | Science Applications International Corp | KEENE NAZZIC S | Director, Officer - Chief Executive Officer | Services-Computer Integrated Systems Design | BUY | $70.75 | 14,300 | $1,011,769 | 50,624 | +39.4% |
| 2020-04-08 01:19 | 2020-04-03 | SPWR | N/A | TOTAL S.A. | Director, 10% owner | Other | BUY | $4.91 | 852,511 | $4,188,387 | 86,859,238 | +1.0% |
| 2020-04-07 20:56 | 2020-04-03 | MYOV | Myovant Sciences Ltd. | Sumitomo Chemical Co., Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $8.18 | 140,000 | $1,145,452 | 47,068,604 | +0.3% |
| 2020-04-08 02:28 | 2020-04-03 | NGM | N/A | Svennilson Peter | Director, 10% owner | Other | BUY | $14.17 | 138,315 | $1,960,228 | 17,594,376 | +0.8% |
| 2020-04-08 02:21 | 2020-04-03 | NGM | N/A | COLUMN GROUP L P | 10% owner | Other | BUY | $14.17 | 138,315 | $1,960,228 | 1,427,469 | +10.7% |
| 2020-04-07 23:16 | 2020-04-03 | NXRT | NexPoint Residential Trust, Inc. | DONDERO JAMES D | Director, Officer - President | Real Estate Investment Trusts | BUY | $21.81 | 94,500 | $2,061,045 | 329,533 | +40.2% |
| 2020-04-08 02:26 | 2020-04-03 | NGM | N/A | GOEDDEL DAVID V | Director, 10% owner | Other | BUY | $14.17 | 138,315 | $1,960,228 | 17,784,376 | +0.8% |
| 2020-04-08 00:23 | 2020-04-03 | MGM | MGM Resorts International | SALEM PAUL J | Director | Hotels & Motels | BUY | $10.40 | 195,000 | $2,027,025 | 1,517,000 | +14.8% |
| 2020-04-07 16:30 | 2020-04-06 | CUK | CARNIVAL PLC | WEISENBURGER RANDALL J | Director | Water Transportation | BUY | $8.00 | 1,250,000 | $10,000,000 | 1,375,352 | +997.2% |
| 2020-04-07 16:26 | 2020-04-06 | CCL | CARNIVAL CORP | WEISENBURGER RANDALL J | Director | Water Transportation | BUY | $8.00 | 1,250,000 | $10,000,000 | 1,375,352 | +997.2% |
| 2020-04-07 02:04 | 2020-03-27 | NLTX | Neurogene Inc. | Redmile Group, LLC | 10% owner | Pharmaceutical Preparations | BUY | $10.35 | 194,300 | $2,011,277 | 4,051,045 | +5.0% |
| 2020-04-06 23:42 | 2020-04-02 | NCMI | National CineMedia, Inc. | Standard General L.P. | 10% owner | Services-Advertising | BUY | $2.61 | 715,025 | $1,868,789 | 18,939,756 | +3.9% |
| 2020-04-06 23:01 | 2020-03-23 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Other | BUY | $4.14 | 1,037,277 | $4,292,563 | 68,515,644 | +1.5% |
| 2020-04-07 03:31 | 2020-04-03 | EQIX | EQUINIX INC | Luby William K | Director | Real Estate Investment Trusts | BUY | $632.22 | 5,000 | $3,161,100 | 38,427 | +15.0% |
| 2020-04-04 01:16 | 2020-04-01 | CVNA | CARVANA CO. | CVAN Holdings LLC | 10% owner | Retail-Auto Dealers & Gasoline Stations | BUY | $45.00 | 400,000 | $18,000,000 | 900,000 | +80.0% |
| 2020-04-04 01:03 | 2020-04-02 | CDLX | Cardlytics, Inc. | SOSIN CLIFFORD | 10% owner | Services-Computer Programming, Data Processing, Etc. | BUY | $30.90 | 47,700 | $1,474,078 | 4,041,249 | +1.2% |
| 2020-04-04 01:13 | 2020-04-02 | FTAI | FTAI Aviation Ltd. | WASHINGTON STATE INVESTMENT BOARD | 10% owner | Services-Miscellaneous Equipment Rental & Leasing | BUY | $8.50 | 2,353,400 | $19,998,958 | 11,785,779 | +25.0% |
| 2020-04-04 01:07 | 2020-04-01 | HDS | N/A | Wolfe Lauren Taylor | Director | Other | BUY | $26.23 | 267,584 | $7,018,327 | 1,181,702 | +29.3% |
| 2020-04-03 21:35 | 2020-04-01 | SPWR | N/A | TOTAL S.A. | Director, 10% owner | Other | BUY | $4.80 | 1,028,575 | $4,934,383 | 86,006,727 | +1.2% |
| 2020-04-03 22:04 | 2020-04-01 | MYOV | Myovant Sciences Ltd. | Sumitomo Chemical Co., Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $7.60 | 140,000 | $1,063,384 | 46,928,604 | +0.3% |
| 2020-04-03 23:30 | 2020-04-01 | PHAT | Phathom Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $24.86 | 117,600 | $2,923,642 | 3,825,008 | +3.2% |
| 2020-04-03 23:08 | 2020-04-01 | CVNA | CARVANA CO. | GARCIA ERNEST C. II | 10% owner | Retail-Auto Dealers & Gasoline Stations | BUY | $45.00 | 555,556 | $25,000,020 | 555,556 | +100.0% |
| 2020-04-03 01:44 | 2020-03-31 | CDLX | Cardlytics, Inc. | SOSIN CLIFFORD | 10% owner | Services-Computer Programming, Data Processing, Etc. | BUY | $35.56 | 65,034 | $2,312,453 | 3,966,549 | +1.7% |
| 2020-04-03 00:01 | 2018-02-06 | SHLX | N/A | Shell Pipeline Co LP | 10% owner | Other | BUY | $1.66 | 180,507,168 | $300,002,913 | 269,457,304 | +202.9% |
| 2020-04-03 01:16 | 2020-03-31 | NGM | N/A | Svennilson Peter | Director, 10% owner | Other | BUY | $12.40 | 250,984 | $3,111,022 | 17,456,061 | +1.5% |
| 2020-04-03 00:59 | 2020-03-31 | APPN | Appian Corporation | Abdiel Capital Management, LLC | 10% owner | Services-Prepackaged Software | BUY | $38.39 | 384,419 | $14,757,000 | 7,809,473 | +5.2% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.